Results 91 to 100 of about 54,016 (263)

Statin Use Is Associated with Bladder Pain Syndrome/Interstitial Cystitis: A Population-Based Case-Control Study

open access: yes, 2017
Introduction: Statin may induce epithelial dysfunction of the bladder urothelium. Epithelial dysfunction was proposed as one of the major potential etiologies for bladder pain syndrome/interstitial cystitis (BPS/IC).
黃昭淵   +1 more
core   +1 more source

Eosinophilic Cystitis and Interstitial Cystitis: may allergy be the reason? [PDF]

open access: yes, 2015
 Allergic diseases have increased in prevalence during recent years. Although they impose numerous health and financial burden on patients and their family and also the society, they are to some extent preventable and manageable.
Mansouri, Mahboubeh
core   +1 more source

Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1‐LaserComplete study)

open access: yesBJU International, EarlyView.
Objectives To evaluate ex vivo fluorescence confocal microscopy (FCM) for immediate detrusor muscle (DM) assessment during primary transurethral resection of bladder tumour (TURBT). Patients and Methods This prospective, blinded, paired‐cohort feasibility study enrolled consecutive patients undergoing primary TURBT for suspected non‐muscle‐invasive ...
Martin J. Connor   +20 more
wiley   +1 more source

Eosinophilic cystitis mimics bladder tumor: A rare case report

open access: yesHeliyon
Eosinophilic cystitis is a rare inflammatory condition of the bladder characterized by eosinophils infiltrating the bladder wall. It affects people of all ages and with no gender difference.
Moatasem Hussein Al-janabi   +3 more
doaj   +1 more source

Association of dysmenorrhea with interstitial cystitis/bladder pain syndrome: a case-control study

open access: yes, 2017
Objective. Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disabling condition of the urological system. Many gynecological conditions are reported to be associated with IC/BPS. This study presents epidemiological evidence of a possible
Chung, Shiu-Dong;Liu, Shih-Ping;Lin, Herng-Ching;Kang, Jiunn-Horng   +1 more
core   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Features of cystitis management in outpatient therapeutic practic

open access: yesЛечащий Врач
Background. Cystitis is one of the most common urinary tract infections undergoing treatment on an outpatient basis. In Russia, up to 36 million cases of the disease are registered annually. The main causative agent of uncomplicated cystitis, detected in
D. S. Sukhanov   +3 more
doaj   +1 more source

Calcifying nanoparticles associated encrusted urinary bladder cystitis

open access: yes, 2008
Tomislav M Jelic1, Rod Roque1, Uzay Yasar2, Shayna B Tomchin1, Jose M Serrato2, Samuel G Deem3, James P Tierney3, Ho-Huang Chang11Department of Pathology Charleston Area Medical Center, Charleston WV, USA; 2Urology Center of Charleston, Charleston WV ...
Shayna B Tomchin   +5 more
core  

Cystitis and its management [PDF]

open access: yes, 2016
Urinary tract infections are very common. They are responsible for over 6 million patient visits to doctors per year in the United States. These include over 2 million cases that are attributed to cystitis which is the most common urinary tract infection.
Soler, Gillian
core  

Optimising Haematopoietic Stem Cell Transplantation: Enhancing Myeloablation Sensitivity and Alleviating Anaemia Using Roxadustat (FG‐4592)

open access: yesCell Proliferation, EarlyView.
The use of FG‐4592 in the process of myeloablation can promote haematopoietic cell apoptosis for more effective myeloablation, maintain the number of RBC and may create a pluripotent microenvironment suitable for donor cells, so as to enable more effective haematopoietic reconstruction of donor cells in vivo.
Guanheng Yang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy